Sunnyvale, CA · Founded 2013 · Privately Held (backing)
Developer of medical devices designed for arterial embolization procedures. Embolx is based in Sunnyvale, CA and was founded in 2013. Its last reported valuation was $37.6 million in Jul 2021. It has raised $16.5 million across 3 recorded rounds; the latest was a $1.6 million seed round in Oct 2022.
Last reported valuation
$37.6M
Oct 2026
Priced at
—
Total raised
$16.5M
Last round
Seed Round
Oct 2022
Cap table — not yet on record
Embolx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Embolx with a free account
·The complete investor list: 14 names
·Watch Embolx: the Monday email on marks, rounds and moves